Pro Medicus Limited (ASX:PME) shares storm to an all-time high on bumper profit growth

The Pro Medicus Limited (ASX:PME) share price has stormed to an all-time high after delivering bumper profit growth in FY 2018. Should you invest?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In early trade the Pro Medicus Limited (ASX: PME) share price pushed 4.5% higher to an all-time high of $9.09 following the release of the imaging IT provider's full year results.

For the 12 months ended June 30 2018, Pro Medicus posted a 13.9% increase in revenue to $36 million and a 36.7% jump in profit after tax to $12.7 million. Underlying profit, excluding currency movements, was up 27.4% to $12.6 million.

As shown below, the main driver of this growth was the positive performance of its North American and European operations. Revenue in these segments increased 18.4% and 33.2%, respectively, in FY 2018. This made up for a soft performance from its Australian operation.

Source: Company presentation

The North American segment was given a boost from the signing of three key contracts. This included an A$18 million, seven-year contract with Yale New Haven Health, one of the leading academic institutions and a A$15 million, seven-year contract with Mercy Health for Visage Open Archive.

Pro Medicus' strong bottom line growth was largely down to its North American business. CEO Sam Hupert stated that: "The key driver for margin and revenue growth was our North American business. We brought more sites online so had a good year in terms of professional services, which includes implementation and training. Those sites that were online continued to build their transaction volumes which is pretty much what we expected, so we're very pleased with that."

Before adding that: "Looking at margins, we've always said that the US is a higher margin business and therefore the greater the contribution from the US the higher the margins in total. As we grow this business and build our base of recurring transaction revenues in that market we should see further margin expansion."

This ultimately led to earnings per share of 12.2 cents, up from 9 cents per share in FY 2017. And with the company remaining debt-free and seeing its cash reserves rise 10.8% to $25.2 million, the board was able to increase its full-year dividend by 50% to a fully franked 6 cents per share.

Should you invest?

As I mentioned yesterday, I think Pro Medicus is up there with Nanosonics Ltd (ASX: NAN) and Volpara Health Technologies Ltd (ASX: VHT) as one of the best medical technology shares on the Australian share market.

There's no denying that its shares are expensive at 75x earnings and carry a lot of risk, but I remain confident that it can grow at a level that justifies this premium over the long-term.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited, PRO Medicus Ltd., and VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Share Gainers

Why Cettire, Gold Road, Imugene, and Paladin Energy shares are racing higher

These shares are ending the week with a bang. But why? Let's find out.

Read more »

A woman wearing headphones looks delighted and animated on news she's receiving from her mobile phone that she is holding close to her face.
Share Gainers

Why Brainchip, Fortescue, Mesoblast, and QBE shares are racing higher today

These shares are starting the year in a positive fashion. But why?

Read more »

Multiracial happy young people stacking hands outside - University students hugging in college campus - Youth community concept with guys and girls standing together supporting each other.
Share Gainers

These were the 5 best performing ASX 200 shares in 2024

Let's see why these shares delivered massive returns last year.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Share Gainers

These were the best ASX 200 shares to own in December

Let's see why these shares outperformed the market in December.

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Share Gainers

Why DroneShield, Invictus Energy, Mesoblast, Weebit Nano shares are rising today

These shares are on course to end the year on a positive note. But why?

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Brainchip, Imricor, Strike Energy, and Wildcat shares are rising today

Why are these shares starting the week strongly? Let's find out.

Read more »

Emotional euphoric young woman giving high five to male partner, celebrating family achievement, getting bank loan approval, or financial or investing success.
Share Gainers

Why Bowen Coal, Droneshield, Mesoblast, and St Barbara shares are racing higher today

These shares are ending the week positively. But why?

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Avita Medical, GenusPlus, Mesoblast, and Polynovo shares are storming higher

These shares are having a better day than most today. But why?

Read more »